Top 5 Frequently Asked Questions About Tirzepatide
Our Clinic Manager, Emily, goes over the frequently asked questions we get about Tirzepatide!
Weight Loss
What is Tirzepatide?
Tirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist.
Tirzepatide, the new FDA approved medication for weight loss?
Tirzepatide, FDA approved medication for weight loss November 9, 2023: Update on FDA approval for Tirzepatide for weight loss. A revolutionary weight loss medication, Tirzepatide, has received approval from the U.S. Food and Drug Administration (FDA), marking a significant milestone in the treatment of obesity. This novel medication has shown promising results in clinical trials, …
Tirzepatide, the new FDA approved medication for weight loss? Read More »